ARQL - sorry I didn't post this one over the weekend. However, I still think it'll be in play for a while. Rumors of being a buyout target after their clinical trial results floating around now. (Know the news, trade the action) 8 is the short-term max pain area going forward. Meaning if you buy dips or the next breakout, 8 should be your stop-out point if it fails. Otherwise, it may be worth holding onto a few days. Similar setup to the ARWR action covered here.